New test detects bowel cancer five years before it happens
Now, a study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in the next five ...
Algorithm study 90% accurate predicting bowel cancer
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
New bowel cancer detection method more than 90% accurate, research finds
The study, funded by Cancer Research UK, could lead to a blood test which will inform doctors which inflammatory bowel ...
NewsX8h
New Groundbreaking Test Might Predict Bowel Cancer Risk With Up To 90% Accuracy
Scientists have developed a groundbreaking test that may predict bowel cancer risk with up to 90% accuracy. The research, ...
Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress
Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...
Ibj.com20h
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
The Korea Bizwire6h
South Korean Pharmaceutical Companies Make Bold Push Into Autoimmune Disease Market
Celltrion, a leading Korean biotechnology firm, has successfully developed Zymfentra, a subcutaneous version of the company’s ...
KXLY 4 News15h
Superfund listing gives hope to people of Northport
For decades, people in this area have been dealing with unusually high rates of serious health problems, such as multiple sclerosis, ulcerative colitis, Crohn’s disease, and various ...
Teva reports Q4 EPS 71c, consensus 70c
Reports Q4 revenue $4.2B, consensus $4.12B. Richard Francis, Teva‘s (TEVA) President and CEO, said: “2024 marked a transformative year for ...
Breakthrough test with 90 per cent accuracy could help 500,000 people in UK at high risk of cancer
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...